Stromal expression of decorin, semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Henke, Alexander ^a,c   Grace, O Cathal ^a,d   Ashley, George R ^a,e   Stewart, Grant D ^b   Riddick, Antony C P ^b   Yeun, Henry ^b   O'Donnell, Marie ^b   Anderson, Richard A ^a   Thomson, Axel A ^a,f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

^e PrimerDesign Ltd   (United Kingdom)

^f Edificio BIC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; OSTEONECTIN; PROSTATE PROTEIN; SEMAPHORIN; SEMAPHORIN 6D; SPROUTY 1 PROTEIN; SPROUTY PROTEIN; TSUKUSHI PROTEIN; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESENCHYME; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PERINATAL PERIOD; PROSTATE CANCER; PROSTATE DEVELOPMENT; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

ANIMALS; DECORIN; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MEMBRANE PROTEINS; MESODERM; NERVE TISSUE PROTEINS; OSTEONECTIN; PHOSPHOPROTEINS; PROSTATE; PROSTATIC NEOPLASMS; PROTEOGLYCANS; RATS; RATS, WISTAR; RNA, MESSENGER; SEMAPHORINS; STROMAL CELLS;

RATTUS;

EID: 84864551113     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042516     Document Type: Article

References (61)

1. Cunha GR, Chung LW, Shannon JM, Taguchi O, Fujii H, (1983) Hormone-induced morphogenesis and growth: Role of mesenchymal-epithelial interactions. Recent Prog Horm Res 39: 559-598.
2. Cunha GR, Fujii H, Neubauer BL, Shannon JM, Sawyer L, et al. (1983) Epithelial-mesenchymal interactions in prostatic development. I. morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J Cell Biol 96(6): 1662-1670.
3. Sugimura Y, Cunha GR, Bigsby RM, (1986) Androgenic induction of DNA synthesis in prostatic glands induced in the urothelium of testicular feminized (Tfm/Y) mice. Prostate 9(3): 217-225.
4. Chang HY, Chi J, Dudoit S, Bondre C, van de Rijn M, et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proceedings of the National Academy of Sciences 99(20): 12877-12882.
5. Kassen A, Sutkowski DM, Ahn H, Sensibar JA, Kozlowski JM, et al. (1996) Stromal cells of the human prostate: Initial isolation and characterization. Prostate 28(2): 89-97.
6. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: The next generation. Cell 144(5): 646-674.
7. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59(19): 5002-5011.
8. Kalluri R, Zeisberg M, (2006) Fibroblasts in cancer. Nat Rev Cancer 6(5): 392-401.
9. Allen M, Louise Jones J, (2011) Jekyll and hyde: The role of the microenvironment on the progression of cancer. J Pathol 223(2): 162-176.
10. San Francisco IF, DeWolf WC, Peehl DM, Olumi AF, (2004) Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts. Int J Cancer 112(2): 213-218.
11. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, et al. (2005) Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 24(32): 5053-5068.
12. Orr B, Riddick AC, Stewart GD, Anderson RA, Franco OE, et al. (2012) Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate. Oncogene 31(9): 1130-1142.
13. Franco OE, Jiang M, Strand DW, Peacock J, Fernandez S, et al. (2011) Altered TGF-beta signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res 71(4): 1272-1281.
14. Kiskowski MA, Jackson RS,2nd, Banerjee J, Li X, Kang M, et al (2011) Role for stromal heterogeneity in prostate tumorigenesis. Cancer Res 71(10): 3459-3470.
15. Hayashi N, Cunha GR, (1991) Mesenchyme-induced changes in the neoplastic characteristics of the dunning prostatic adenocarcinoma. Cancer Res 51(18): 4924-4930.
16. McNeal JE, (1978) Origin and evolution of benign prostatic enlargement. Invest Urol 15(4): 340-345.
17. Vanpoucke G, Orr B, Grace OC, Chan R, Ashley GR, et al. (2007) Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease. Genome Biol 8(10): R213.
18. Orr B, Grace OC, Vanpoucke G, Ashley GR, Thomson AA, (2009) A role for notch signaling in stromal survival and differentiation during prostate development. Endocrinology 150(1): 463-472.
19. Ashley GR, Grace OC, Vanpoucke G, Thomson AA, (2010) Identification of EphrinB1 expression in prostatic mesenchyme and a role for EphB-EphrinB signalling in prostate development. Differentiation 80(2-3): 89-98.
20. Orr B, Vanpoucke G, Grace OC, Smith L, Anderson RA, et al. (2010) Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia. Prostate.
21. Timms BG, (2008) Prostate development: A historical perspective. Differentiation 76(6): 565-577.
22. Pritchard C, Mecham B, Dumpit R, Coleman I, Bhattacharjee M, et al. (2009) Conserved gene expression programs integrate mammalian prostate development and tumorigenesis. Cancer Res 69(5): 1739-1747.
23. Prins GS, Jung MH, Vellanoweth RL, Chatterjee B, Roy AK, (1996) Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia. Dev Genet 18(2): 99-106.
24. Fleischmajer R, Fisher LW, MacDonald ED, Jacobs L, Jr, Perlish JS, et al. (1991) Decorin interacts with fibrillar collagen of embryonic and adult human skin. J Struct Biol 106(1): 82-90.
25. Yamaguchi Y, Mann DM, Ruoslahti E, (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346(6281): 281-284.
26. Yamaguchi Y, Ruoslahti E, (1988) Expression of human proteoglycan in chinese hamster ovary cells inhibits cell proliferation. Nature 336(6196): 244-246.
27. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, et al. (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360(6402): 361-364.
28. Tomlinson DC, Freestone SH, Grace OC, Thomson AA, (2004) Differential effects of transforming growth factor-beta1 on cellular proliferation in the developing prostate. Endocrinology 145(9): 4292-4300.
29. Zhao J, Sime PJ, Bringas P, Jr, Gauldie J, Warburton D, (1999) Adenovirus-mediated decorin gene transfer prevents TGF-beta-induced inhibition of lung morphogenesis. Am J Physiol 277(2 Pt 1): L412-22.
30. Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K, et al. (1998) Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 4(4): 963-971.
31. Stander M, Naumann U, Wick W, Weller M, (1999) Transforming growth factor-beta and p-21: Multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 296(2): 221-227.
32. Hu Y, Sun H, Owens RT, Wu J, Chen YQ, et al. (2009) Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways. Neoplasia 11(10): 1042-1053.
33. Bi X, Pohl NM, Qian Z, Yang GR, Gou Y, et al. (2012) Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 33(2): 326-330.
34. Stock C, Jungmann O, Seidler DG, (2011) Decorin and chondroitin-6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification. J Cell Physiol 226(10): 2641-2650.
35. Iozzo RV, Buraschi S, Genua M, Xu SQ, Solomides CC, et al. (2011) Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem 286(40): 34712-34721.
36. Altenberg B, Greulich KO, (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84(6): 1014-1020.
37. Putzke AP, Ventura AP, Bailey AM, Akture C, Opoku-Ansah J, et al. (2011) Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases. Am J Pathol 179(1): 400-410.
38. Larsson O, Girnita A, Girnita L, (2005) Role of insulin-like growth factor 1 receptor signalling in cancer. Br J Cancer 92(12): 2097-2101.
39. Gorlov IP, Sircar K, Zhao H, Maity SN, Navone NM, et al. (2010) Prioritizing genes associated with prostate cancer development. BMC Cancer 10: 599.
40. Trevino V, Tadesse MG, Vannucci M, Al-Shahrour F, Antczak P, et al. (2011) Analysis of normal-tumour tissue interaction in tumours: Prediction of prostate cancer features from the molecular profile of adjacent normal cells. PLoS One 6(3): e16492.
41. Blum G, Gazit A, Levitzki A, (2003) Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics. J Biol Chem 278(42): 40442-40454.
42. Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, et al. (2010) Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A 107(46): 20009-20014.
43. Gerdes MJ, Larsen M, Dang TD, Ressler SJ, Tuxhorn JA, et al. (2004) Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1. Prostate 58(3): 299-307.
44. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR, (2002) Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res 62(21): 6021-6025.
45. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, et al. (2002) Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8(9): 2912-2923.
46. Thomson AA, (2001) Role of androgens and fibroblast growth factors in prostatic development. Reproduction 121 (2): 187-195.
47. Coulson-Thomas VJ, Gesteira TF, Coulson-Thomas YM, Vicente CM, Tersariol IL, et al. (2010) Fibroblast and prostate tumor cell cross-talk: Fibroblast differentiation, TGF-beta, and extracellular matrix down-regulation. Exp Cell Res 316(19): 3207-3226.
48. Steer DL, Shah MM, Bush KT, Stuart RO, Sampogna RV, et al. (2004) Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev Biol 272(2): 310-327.
49. Toyofuku T, Zhang H, Kumanogoh A, Takegahara N, Suto F, et al. (2004) Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev 18(4): 435-447.
50. Strandjord TP, Sage EH, Clark JG, (1995) SPARC participates in the branching morphogenesis of developing fetal rat lung. Am J Respir Cell Mol Biol 13(3): 279-287.
51. Caruana G, Cullen-McEwen L, Nelson AL, Kostoulias X, Woods K, et al. (2006) Spatial gene expression in the T-stage mouse metanephros. Gene Expr Patterns 6(8): 807-825.
52. Said N, Frierson HF, Jr, Chernauskas D, Conaway M, Motamed K, et al. (2009) The role of SPARC in the TRAMP model of prostate carcinogenesis and progression. Oncogene 28(39): 3487-3498.
53. Mason JM, Morrison DJ, Basson MA, Licht JD, (2006) Sprouty proteins: Multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 16(1): 45-54.
54. Akbulut S, Reddi AL, Aggarwal P, Ambardekar C, Canciani B, et al. (2010) Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase C. Mol Biol Cell. 21(19): 3487-3496.
55. Basson MA, Akbulut S, Watson-Johnson J, Simon R, Carroll TJ, et al. (2005) Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev Cell 8(2): 229-239.
56. Chi L, Zhang S, Lin Y, Prunskaite-Hyyrylainen R, Vuolteenaho R, et al. (2004) Sprouty proteins regulate ureteric branching by coordinating reciprocal epithelial Wnt11, mesenchymal gdnf and stromal Fgf7 signalling during kidney development. Development 131(14): 3345-3356.
57. Ohta K, Lupo G, Kuriyama S, Keynes R, Holt CE, et al. (2004) Tsukushi functions as an organizer inducer by inhibition of BMP activity in cooperation with chordin. Dev Cell 7(3): 347-358.
58. Ohta K, Kuriyama S, Okafuji T, Gejima R, Ohnuma S, et al. (2006) Tsukushi cooperates with VG1 to induce primitive streak and hensen's node formation in the chick embryo. Development 133(19): 3777-3786.
59. Kuriyama S, Lupo G, Ohta K, Ohnuma S, Harris WA, et al. (2006) Tsukushi controls ectodermal patterning and neural crest specification in xenopus by direct regulation of BMP4 and X-delta-1 activity. Development 133(1): 75-88.
60. Morris SA, Almeida AD, Tanaka H, Ohta K, Ohnuma S, (2007) Tsukushi modulates Xnr2, FGF and BMP signaling: Regulation of xenopus germ layer formation. PLoS One 2(10): e1004.
61. Ito A, Shinmyo Y, Abe T, Oshima N, Tanaka H, et al. (2010) Tsukushi is required for anterior commissure formation in mouse brain. Biochem Biophys Res Commun 402(4): 813-818.